Taking into account all these considerations, the concept that restoring ABCB1 at the BBB could be a valid therapeutic strategy to lower Aβ brain load, reduce cognitive decline, delay onset, and slow progression of AD has to be critically evaluated. This evidence concerns the gene ABCB1 and Mental deterioration.